Explore more publications!

Louisiana Tech Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Louisiana Tech Review.

Press releases published on October 24, 2025

Breaking News: While Bitcoin, XRP, and gold are experiencing market turmoil, cryptocurrency industry insiders are quietly transferring funds to WOA Hash achieve stable growth of digital assets
As Inflation Rises, Smart Investors Turn to NB HASH — The AI Hashrate Platform Redefining Digital Wealth
BEYOND Launches Web3.0 AI Cloud Computing Platform — Start Your Intelligent Wealth Growth Journey
SLC Appoints Veena Dandapani as Chief Operating Officer to Drive Global Expansion and Advance SIM-Based Identity Innovation
Syndax Announces FDA Approval of Revuforj® (revumenib) in Adult and Pediatric Patients with Relapsed or Refractory NPM1 Mutated Acute Myeloid Leukemia
K12 Wins Two Silver Medals at 2025 International Serious Play Awards
Sionna Therapeutics Announces Presentation of SION-719 and SION-451 Phase 1 Data and Poster of New Preclinical Data on the Impact of NBD1 Stabilizers on F508del-CFTR Half-Life at the 2025 North American Cystic Fibrosis Conference
BlossomHill Therapeutics Presents Preliminary Findings from Phase 1/2 SOLARA Trial of BH-30643 in EGFR-mutant NSCLC at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Surfshark launches a privacy-first web content blocker
Ironwood Academy Launches to Redefine Financial Learning
YCTF Industrial Hardware Agency Revolutionizes Supply Chain with Full-Category In-Stock Direct Supply, Offering 30% Cost Savings and 50% Faster Delivery — Trusted by 2,000+ Global Enterprises
PMV Pharmaceuticals Announces Updated Rezatapopt Monotherapy Interim Data From Ongoing PYNNACLE Phase 2 Trial Across Multiple Solid Tumors With a TP53 Y220C Mutation
《Rebel Engine》於 Steam Next Fest 顯示強勁表現後,Snail Games 重點展示公司產品組合增長動能
Halda Therapeutics Announces First-in-Human Results for HLD-0915, an Oral RIPTAC™ Therapeutic Demonstrating Encouraging Safety and Anti-Tumor Activity in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Remix Therapeutics Announces Positive Preliminary Data from Phase 1 Study of REM-422 in Patients with Adenoid Cystic Carcinoma at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
MicroCloud Hologram Inc. Releases Hybrid Quantum-Classical Convolutional Neural Network, Achieving New Breakthrough in MNIST Multi-Class Classification
Carahsoft and Partners Showcase Education, Cybersecurity and AI Solutions at Educause Annual Conference on October 27-30, 2025 in Nashville, TN
Evolving Treatment Landscape for Chronic Spontaneous Urticaria Highlights Significant Unmet Needs and Expanding Opportunities for Therapeutic Innovation
Citrine Global Corp. (DBA SkyTech Orion Global Corp.) (OTCQB: CTGL) today issued a shareholder update letter from the Company’s Chairwoman and Chief Executive Officer, Ora Elharar-Soffer
Canatu grants license for commercial production of CNT pellicle membranes using CNT100 SEMI reactor

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions